ABSTRACT: Five groups of salmon, of initial mean weight 127 ± 3 g, were fed increasing levels of dietary linseed oil (LO) in a regression design. The control diet contained capelin oil (FO) only, and the same oil was blended with LO to provide the experimental diets. After an initial period of 40 wk, all groups were switched to a finishing diet containing only FO for a further 24 wk. Growth and flesh lipid contents were not affected by dietary treatment. The FA compositions of flesh total lipids were linearly correlated with dietary FA compositions (r 2 = 0.88-1.00, P < 0.0001). LO included at 50% of added dietary lipids reduced flesh DHA and EPA (20:5n-3) concentrations to 65 and 58%, respectively, of the concentrations in fish fed FO. Feeding 100% LO reduced flesh DHA and EPA concentrations to 38 and 30%, respectively, of the values in fish fed FO. Differences between diet and flesh FA concentrations showed that 16:0, 18:1n-9, and especially DHA were preferentially retained in flesh, whereas 18:2n-6, 18:3n-3, and 22:1n-11 were selected against and presumably utilized for energy. In fish previously fed 50 and 100% LO, feeding a finishing diet containing FO for 16 wk restored flesh DHA and EPA concentrations, tõ 80% of the values in fish fed FO throughout. Flesh DHA and EPA concentrations in fish fed up to 50% LO were above recommended intake values for humans for these EFA. This study suggests that LO can be used as a substitute for FO in seawater salmon feeds and that any reductions in DHA and EPA can be largely overcome with a finishing diet high in FO before harvest.
The importance of the n-3 PUFA, and specifically the n-3 highly unsaturated FA (HUFA) DHA (22:6n-3) and EPA (20:5n-3) , in human nutrition is now widely recognized (1, 2) . There is also increasing evidence that a range of conditions currently prevalent in the developed world, including cardiovascular disease, diabetes, rheumatoid arthritis, neurological disorders, and metabolic disorders such as diabetes and obesity, are influenced by changes in dietary FA intake (3) .
Fish, particularly those with high levels of body fat, such as salmon, herring, and sardines, represent a rich source of EPA and DHA for the human consumer. Owing to increased population pressure, worldwide demand for seafood is increasing, yet traditional food-grade fisheries are unable to match demand with supply (4) . Increased demand has resulted in rapid expansion of aquaculture production to alleviate this potential seafood deficit (5, 6) . However, the feed-grade fisheries that have supplied the raw materials for aquaculture feeds have reached sustainable limits, and it is estimated that by the year 2010 more than 85% of world fish oil (FO) supplies will be used for aquaculture production (7) . Consequently, continued expansion of the aquaculture industry can occur only if sustainable alternatives to FO, derived from terrestrial plants, are researched and implemented.
The lipids in feeds for Atlantic salmon must meet both energy and EFA requirements to allow for the rapid growth and development required in modern aquaculture production (8, 9) . Earlier studies on β-oxidation activity suggest that salmonid fish have a preference for 16:0, 16:1, 18:1n-9, and 22:1n-11, as well as 18:2n-6 (10, 11) , although more recent studies with salmon and rainbow trout suggest that 18:3n-3 and 20:5n-3 may also be utilized for energy production when present at higher concentrations (12) (13) (14) . The high-latitude FO that are currently favored in salmon production are very rich in 20:1n-9 and 22:1n-11, whereas different vegetable oils are rich in 16:0, 18:1n-9, 18:2n-6, and 18:3n-3. Several recent studies have shown that salmon can be cultured for up to 30 wk using diets formulated with up to 100% replacement of added FO by vegetable oils (15) (16) (17) (18) . The ability to convert C 18 PUFA to their long-chain HUFA products has been confirmed in Atlantic salmon, as has the up-regulation of these pathways in hepatocytes and enterocytes of fish fed vegetable oil-containing diets (19, 20) . However, the increased flux through the FA desaturation and elongation pathway is unlikely to compensate fully for reduced dietary EPA, DHA, and possibly arachidonic acid requirements; thus, a sufficient dietary supply of these HUFA will need to be provided (12, 13) .
Atlantic salmon fed diets containing raw materials of predominantly marine origin are of high nutritional quality, being rich in EPA and DHA and with an n-3/n-6 ratio of around 4:1 (21, 22) . Recent studies have shown that salmon cultured using diets in which >50% of added FO has been replaced with vegetable oil show significant reductions in flesh EPA and DHA concentrations (14) (15) (16) (17) . Obviously, from a human health perspective, any changes to n-3 HUFA content should be kept to a minimum, and any FO replacement should provide sufficient energy alternatives to long-chain monoenes, maximize conversion of dietary 18:3n-3, and preserve endogenous n-3 HUFA levels. In this regard, linseed oil (LO) is an important candidate for FO replacement, not only because it is rich in 18:3n-3, the precursor for n-3 HUFA, but also because 18:3n-3 is a favored substrate for β-oxidation both in salmonid fish and in mammals (12) (13) (14) 23) . Furthermore, increasing salmon flesh concentrations of 18:3n-3 should not be perceived as detrimental, from a human nutrition perspective, as 18:3n-3 has been shown to be beneficial in cardiovascular disease and some forms of cancer (24) , possibly due to inhibition of the conversion of 18:2n-6 to 20:4n-6 and the inhibition of cyclooxygenase (25, 26) . The aim of this study was to determine the effects of replacing FO with LO, in a graded fashion, in terms of growth performance and, more importantly, to assess the changes in flesh FA composition that arise from LO inclusion. The relevance of reducing EPA and DHA concentrations, as well as increasing 18:2n-6 and 18:3n-3 concentrations, is discussed in the context of human nutrition. In addition, the successful restoration of EPA and DHA levels by feeding a FO finishing diet are relevant to human nutrition and to future production protocols for cultured Atlantic salmon.
In the present study, Atlantic salmon post-smolt were stocked into five seawater pens and fed one of four diets containing 25, 50, 75, or 100% LO, or a control diet containing only FO. The fish were grown for 40 wk before sampling, and thereafter fish on all treatments were switched to a diet containing only FO for a further 24 wk to follow the accumulation of DHA and EPA and the dilution of 18:3n-3 and 18:2n-6 from LO.
MATERIALS AND METHODS

Fish and diets.
Atlantic salmon post-smolt (n = 3000) of initial mean weight 127 ± 3 g (individual weights of 50 fish/pen) were distributed into five net pens (5 × 5 m; 600 fish/pen) in Loch Duich, Lochalsh, Scotland, in June 2001. The temperature over the experimental period (June 2001-December 2002) ranged from 5.0 to 16.8°C, with a mean temperature of 10.8 ± 2.2°C. The fish were fed one of four experimental diets in which the FO component was replaced by LO or a control diet containing only FO (capelin oil). Specifically, the five diets were 100% FO (FO); FO/LO, 3:1 w/w (25% LO); FO/LO, 1:1 w/w (50% LO); FO/LO, 1:3 w/w (75% LO); and 100% LO. Feeds were fed to satiation by hand twice a day for a period of 40 wk and all feed fed was recorded. After this time, samples of fish were collected for analysis, and the remaining fish were all switched to the FO diet for a further 24 wk. The 24-wk time frame was chosen to allow as long as possible for the restoration of a marine FA profile and also so that fish did not exceed the normal market weight (5 kg). We were aware that the regression experimental design, with only one replicate per treatment, had statistical limitations. However, this compromise was made to allow growth from 150 g to 2 kg over a period of 40 wk on a commercial scale at reasonable cost. The data obtained are still highly relevant to both the aquaculture industry and to human nutrition. The five practical diet types (Nutreco Aquaculture Research Centre, Stavanger, Norway) were formulated to fully satisfy the nutritional requirements of salmonid fish and differed only in their oil composition (27). The main dietary components (in g kg -1 ) were fishmeal, 338; capelin oil, 0-258, and/or linseed oil 0-258; maize gluten, 200; soy meal, 100; and micronutrients, 25 . The diets were produced in 3-, 6-and 9-mm sizes and had average proximate compositions of 44.1 ± 0.3% crude protein, 29.4 ± 0.6% crude lipids, 7.1 ± 0.45% ash, and 5.9 ± 0.3% moisture. The FA compositions of the experimental diets are shown in Table 1 . The FO diet containing capelin oil contained about 20% saturates, mainly 16:0, and almost 60% monoenes, of which 50% were the long-chain 20:1n-9 and 22:n-11. The FO diet contained 5% n-6 FA, mostly 18:2n-6, and 16% n-3 FA, dominated by EPA and DHA in almost equal amounts and with 18:3n-3 less than 1%. Addition of increasing levels of dietary LO resulted in increasing levels of 18:3n-3, 18:2n-6, and 18:1n-9 and decreasing levels of EPA, DHA, 16:0, total saturates, 20:1n-9, 22:1n-11, and total monoenes. Thus, the 100% LO diet contained 10% total saturates, 21% total monoenes, 15% 18:2n-6, and 50% 18:3n-3, with EPA and DHA accounting for only 2.5% of total dietary FA. Sampling procedures. After 40 wk, 18 fish were selected from each treatment and killed by a blow to the head after anesthetizing them with MS222 (Sigma-Aldrich, Poole, England). A sample of flesh, representative of the edible portion, was obtained by cutting a steak between the leading and trailing edges of the dorsal fin. The samples were combined as six pools of three steaks in each pool. The steaks were frozen on dry ice and stored at -40°C until processed. The steaks were thawed, skinned, and deboned, and the flesh was homogenized in a food processor after removal of the dorsal fat body. The homogenate was frozen immediately and stored at -40°C prior to analysis. During the period in which fish from all treatments were returned to a FO diet, samples were collected after 4, 8, 16, and 24 wk following reintroduction of the FO diet. At each time point, nine fish were sampled from each treatment group and were combined as three pools of three steaks in each pool. The steaks were processed and stored as described above.
Lipid extraction and FA analysis. Total lipids were extracted from 2 g of homogenized muscle by homogenizing in 20 vol of chloroform/methanol (2:1, vol/vol) in an UltraTurrax tissue disrupter (Fisher Scientific, Loughborough, United Kingdom). Total lipids were prepared according to the method of Folch et al. (28) , and nonlipid impurities were removed by washing with 0.88% (wt/vol) KCl. The weight of lipids was determined gravimetrically after evaporation of the solvent and overnight desiccation in vacuo. FAME were prepared by acid-catalyzed transesterification of total lipids according to the method of Christie (29) . Extraction and purification of FAME were performed as described by Ghioni et al. (30) . FAME were separated and quantified by GLC (Vega 8160; Carlo Erba, Milan, Italy) using a 30 m × 0.32 mm i.d. capillary column (CP Wax 52CB; Chrompak, London, United Kingdom) and on-column injection. Hydrogen was used as the carrier gas, and temperature programming was from 50 to 150°C at 40°C min -1 and then to 230°C at 2.0°C min -1 . Individual methyl esters were identified by comparison with known standards and by reference to published data (30, 31) . Data were collected and processed using the Chromcard for Windows (version 1.19) computer package (Thermoquest Italia S.p.A., Milan, Italy).
Statistical analysis. The significance of differences (P < 0.05) between dietary treatments was determined by one-way ANOVA. Differences between means were determined by Tukey's test. Data identified as nonhomogeneous, using Bartlett's test, were subjected to log or arcsin transformation before applying the ANOVA. A regression analysis was used to obtain correlation coefficients and slopes from plots of dietary vs. flesh FA concentrations. ANOVA and the regression analysis were performed using a Graphpad Prism™ (version 3.0) statistical package (Graphpad Software, San Diego, CA).
RESULTS
After feeding the five diets for 40 wk, the final weights of the fish were 1.79 ± 0.40 (FO), 1.89 ± 0.34 (25% LO), 1.90 ± 0.33 (50% LO), 1.87 ± 0.35 (75% LO), and 1.87 ± 0.33 kg (100% LO); there were no significant differences between dietary treatments (P = 0.156, n = 87). Specific growth rates were very similar (% weight gain d -1 ), varying from 0.94 (FO) to 0.98 (25% LO), and feed conversion ratios (dry feed consumed/wet weight gain) varied from 1.29 (25 and 75% LO) to 1.41 (50% LO). Flesh lipid contents varied from 7.4 ± 1.4% (FO) to 8.8 ± 1.7% (25% LO), and flesh astaxanthin contents varied from 3.31 ± 0.58 (FO) to 3.60 ± 0.49 mg kg -1 (50% LO). These values showed no significant differences between dietary treatments. After feeding the finishing diet for 24 wk, the final weights of the fish were 4.50 ± 0.71 (FO), 4.68 ± 0.62 (25% LO), 4.72 ± 0.79 (50% LO), 4.48 ± 0.80 (75% LO), and 4.58 ± 0.67 kg (100% LO); and there were no significant differences between dietary treatments (P = 0.783, n = 20). Specific growth rates were very similar (% weight gain d -1 ), varying from 0.51 (75% LO) to 0.55 (100% LO), and feed conversion ratios (dry feed consumed/wet weight gain) varied from 1.05 (75% LO) to 1.14 (50% LO). Flesh lipid contents varied from 9.6 ± 1.1% (100% LO) to 13.0 ± 2.3% (50% LO). These values showed no significant differences between dietary treatments.
Flesh FA compositions: 40 wk feeding LO-containing diets. The FA compositions of flesh total lipids reflected the changes in dietary FA attributable to increasing inclusion of LO (Table 2) . Total saturated FA decreased significantly with increasing LO inclusion, largely because of significant reductions in both 14:0 and 16:0, although 18:0 was increased with the addition of LO. Total monoene FA were reduced by more than half in fish fed 100% LO compared with those fed FO owing to significant reductions in 16:1n-7, 20:1n-9, and 22:1n-11 with each addition of dietary LO. Total n-6 FA were increased by more than twofold, largely due to 18:2n-6 increasing from 3.9 g/100 g of FA in flesh from fish fed FO to 13.1 g/100 g in fish fed 100% LO. Flesh 20:4n-6 concentrations were significantly lower in fish fed 75 and 100% LO compared with those fed FO. Total n-3 FA were increased significantly with each addition of LO, largely because of increased flesh deposition of 18:3n-3, although the elongation and desaturation products, 20:3n-3 and 20:4n-3, were also increased significantly. However, both EPA and DHA were significantly reduced in the flesh from fish fed LO, with values for EPA and DHA in fish fed 100% LO being reduced to 30 and 38% of values in fish fed FO. The n-3/n-6 ratios were similar for all treatments, being in the range of 3.2-3.6.
Plotting the FA concentration (g/100 g) in flesh lipids ( (Table 3) . This is shown more clearly in Table 3 by comparing the differences (∆ values) between the concentrations of individual FA in dietary and flesh lipids for fish fed the FO, 50% LO, and 100% LO diets. For all the PUFA and HUFA listed in Table 3 , only DHA was present in flesh at a greater concentration than in the diet for all three treatments. This situation is in contrast with both 18:3n-3, which was always present in flesh at a lower concentration than in the diet, and 20:5n-3, which had a higher value in flesh than in the diet only when diet concentrations were low. Palmitic acid (16:0), total saturates, and 18:1n-9 all showed positive ∆ values for each of the three diets, suggesting that both saturated FA and 18:1n-9 were being preferentially retained by the fish. In contrast, 18:2n-6, 18:3n-3, 20:1n-9, and 22:1n-11 were generally discriminated against in terms of flesh deposition, particularly when present at high concentrations in the diet.
Flesh FA compositions: 24 wk feeding a FO finishing diet in all dietary treatments. By returning all experimental treatments to a FO-containing diet for 24 wk, following the initial 40 wk feeding phase, the differences between flesh FA compositions were reduced ( Table 4 ). The concentrations of 16:0 and total saturates were significantly higher only in fish fed FO throughout compared with those previously fed 75 and 100% LO. A similar result was seen for 16:1n-7; 20:1n-9 and 22:1n-11 were significantly different for all treatment groups, although fish previously fed 75% LO were not different from those fed 50 or 100% LO. Concentrations of total monoenes showed similar differences, but the concentration in fish previously fed 100% LO was restored to 80% of the value in fish fed FO throughout. The 18:2n-6 and total n-6 FA concentrations were not different between fish fed either FO or 25% LO, and these two treatments were significantly lower than fish previously fed 75 and 100% LO. Concentrations of flesh 20:4n-6 were restored to similar values for all dietary treatments. The flesh concentrations of 18:3n-3 were significantly higher in fish previously fed 75 and 100% LO compared with fish previously fed 50% or 25% LO or FO. The concentration of EPA was significantly higher in fish fed FO throughout compared with those previously fed 50, 75, and 100% LO. In addition concentrations of 22:5n-3 were significantly higher in fish fed FO throughout compared with all other treatments, which had similar concentrations. The concentration of flesh DHA was significantly higher in fish fed FO throughout compared with fish previously fed 50 and 100% LO. Concentrations of total n-3 FA were significantly higher in fish previously fed 75 and 100% LO compared with fish fed the other three diets.
After feeding the experimental diets for 40 wk, the flesh 18:2n-6 concentrations were significantly different among fish fed FO, 50% LO, and 100% LO (Fig. 3A) , with the highest values in fish fed 100% LO being 236% higher than those in fish fed FO. After feeding the FO-containing finishing diet in all treatments, the 18:2n-6 concentrations were still significantly different between treatments after 56 and 64 wk. However, after 64 wk the 18:2n-6 concentrations in fish previously Table 1 .
fed the 50 and 100% LO diets were reduced by 31 and 44%, respectively, following the 24-wk FO refeeding period (Fig. 3A) . A similar result was observed for 18:3n-3 such that the concentrations in fish previously fed the 50 and 100% LO diets were still significantly different, both from each other and from fish fed FO, after 16 and 24 wk on an FO diet (Fig. 3B) . However, the concentrations of 18:3n-3 in fish previously fed 50 and 100% LO were reduced by 64 and 66%, respectively, following the 24-wk FO refeeding period. After the initial 40-wk feeding period, the flesh concentration of EPA was significantly lower in fish fed 50 and 100% LO compared with those fed FO (Fig. 4A) . After refeeding FO for 16 and 24 wk, the flesh EPA concentration increased such that fish previously fed the 50 and 100% LO diets had similar EPA concentrations, but they were still significantly lower than fish fed FO throughout. However, the flesh concentrations of EPA in fish previously fed 50 and 100% LO were restored to 88 and 83%, respectively, of the concentration in fish fed FO throughout, following the 24-wk FO refeeding period. A very similar result was seen with flesh DHA concentrations in fish previously fed 50 and 100% LO, whereby DHA concentrations were restored to 80 and 83%, respectively, of the concentration in fish fed FO throughout following the 24-wk refeeding period. Interestingly, the flesh EPA and DHA concentrations were restored to 81 and 74% and to 85 and 79%, respectively, for fish previously fed 50 and 100% LO diets, after feeding the FO finishing diet for only 16 wk.
DISCUSSION
Salmon produced using diets containing raw materials with high levels of marine FO currently provide a rich source of the n-3 HUFA, EPA, and DHA that are relatively cheap and highly nutritious (21, 22) . However, the growth in aquaculture required to augment dwindling seafood stocks can be sustained only if alternatives to marine FO can be found (5, 7) . In the present study, graded levels of LO were used to replace FO in the culture of Atlantic salmon to market size with no obvious detriment in terms of the growth and health of the fish. Although a number of previous studies have looked at FO substitution in salmon, most have used smaller fish or ones that were cultured on the experimental feeds for relatively short periods (16, 17, (32) (33) (34) . However, the growth results obtained with the present study using LO compare favorably with studies utilizing soy and rapeseed oils as FO replacements and suggest that the energy requirements of Atlantic salmon can be satisfied by vegetable oils with variable FA compositions (18, 35) . A few studies have investigated LO alone or LO blended with other oils in salmon feeds, and these also have confirmed no obvious effects on growth parameters (14, 33, 34) . Atlantic salmon store high amounts of lipids in their flesh, and in market-size salmon (2-5 kg) lipid levels would normally be in the range of 10-20% of wet weight (21, 22) . Changing the FA composition of salmon diets can affect the composition and quantity of flesh lipid stores, and previous studies using rapeseed and palm oils to replace FO have indicated reduced flesh lipids at replacement levels above 50% (16, 17) . In the present study, fish of ~2 kg had lipid levels of 7.4-8.8%, and there were no significant differences between treatments. In a previous study with salmon harvested at a similar size and fed diets with varying levels of FO, LO, and rapeseed oil, no differences in flesh lipid contents were observed (14) . However, lipid concentrations in the livers of fish from the present dietary trial, reported in a recent publication (19) , showed significantly increased lipid deposition in fish fed diets with >50% LO, suggesting that changes in the dietary FA composition can affect adiposity in specific tissues.
It is well documented that the tissue FA composition in salmonid fish is closely related to the dietary FA composition and that feeding high levels of vegetable oils will strongly influence the flesh FA composition (14) (15) (16) (17) (18) . The results from the present study confirm this relationship in which linear correlations between dietary FA concentrations and flesh FA concentrations are clearly demonstrated. Similar linear relationships have been observed in previous studies in which rapeseed, palm, and blends of rapeseed and LO were used, along with FO, in salmon feed formulations (14, 16, 17) . The present study confirms that individual FA, within a blend of dietary FA, are selectively retained or metabolized, depending on their concentration in the diet and the biological function of the specific FA. In practical terms, these linear correlations (Figs. 1 and 2 ) can be used to predict the flesh concentration of a particular FA, when present in a mixture of FA, derived from blends of LO and FO fed to salmon in seawater.
Additional information on the selective retention or metabolism of different dietary FA present in different oil blends can be obtained from Figures 1 and 2 and from Tables  2 and 3 . One of the most striking effects is the preferential deposition and retention of DHA in flesh lipids, regardless of the concentration present in the diet. The ∆ values in Table 3 show positive values in the range 1.6-3.1 for 100% LO, 50% LO, and FO treatments, indicating that, regardless of dietary concentration, DHA was selectively deposited and retained in salmon flesh. This selectivity presumably reflects the specificity of the fatty acyl transferase enzymes that incorporate the FA into flesh TAG and phospholipids, a phenomenon that has been observed in previous studies with salmon fed different combinations of vegetable oils (14, 16, 17) .
By comparison, the other PUFA and HUFA tended to be directed toward metabolism, presumably largely for energy production rather than deposition, especially when present at high concentrations. When present at low concentrations, only EPA showed a positive ∆ value. In contrast, both 18:2n-6 and especially 18:3n-3 were selected against in terms of flesh deposition. The tendency toward preferential metabolism of C 18 PUFA by β-oxidation has been observed not only in salmonid fish (12, 13) but also in humans, in whom 18:3n-3 was preferred over 18:2n-6 as an oxidative substrate (23) . However, it also should be noted that both 18:2n-6 and 18:3n-3 are substrates for ∆6-desaturase, and Atlantic salmon hepatocytes reportedly tend to favor desaturation and elongation of 18:3n-3 over 18:2n-6 (20, 34) . In addition to PUFA, the long-chain monoene FA that are characteristic of high-latitude FO (9) are thought to be important catabolic substrates. This appeared to be confirmed in the present study, in which 22:1n-11 appeared to be preferred over 20:1n-9 even though the former was less abundant in the diets than the latter. The literature suggests that 22:1n-11 and 18:2n-6 are preferred substrates for β-oxidation, along with 16:0, 16:1, and 18:1n-9 (11, 36, 37) . However, in the present study 16:0, and especially 18:1n-9, had positive ∆ values (Table 3) , indicating that these two FA were being selectively retained in flesh lipids rather than being metabolized for energy production. This is in contrast to two previous studies, which showed that 18:1n-9 was used for energy production by the β-oxidation pathway in salmon fed diets containing blends of LO and rapeseed oil, although both 18:2n-6 and 18:3n-3 appeared to be preferred over 18:1n-9 (14, 35) . Perhaps these differences can be explained in part by genetic differences in the salmon stock used in the different trials. The selection of 18:1n-9 and 16:0 for deposition, rather than mobilization, in flesh may reflect the structural function of these FA in membrane phospholipids, where they are often located in the sn-1 position of phospholipids, especially of PC and PE, with HUFA being favored in the sn-2 position (9,38).
The diet of early humans pursuing a hunter/gatherer lifestyle was probably considerably lower in fat and had an n-6/n-3 ratio of around 1:1, in comparison with the current diet in the developed world with an n-6/n-3 ratio of 10-20:1 (39) . The health benefits of diets rich in EPA and DHA, which can reduce this high n-6/n-3 ratio, are well documented, and the outcome of a number of conditions prevalent in the developed world, including cardiovascular disease, immune dysfunction, diabetes, and other inflammatory disorders, can be improved as a result (40) (41) (42) . Although outcomes of clinical trials with 18:3n-3 have been less clear than those with n-3 HUFA, evidence exists that diets promoting increased tissue levels of 18:3n-3 also can be beneficial to health (24) . The benefits of increased 18:3n-3 for cardiovascular disorders, including rhythm disorders, myocardial infarctions, sudden cardiac death, and coronary thrombosis, have been reported (43) (44) (45) . In addition, some studies have reported low tissue levels of 18:3n-3 as a risk factor for both breast and prostate cancers (46, 47) .
Atlantic salmon presently cultured using only marine FO are rich in n-3 HUFA and, as such, represent a valuable source of EPA and DHA for the human consumer (21, 22) . The present study suggests that when salmon are cultured with LO replacing up to 50% of FO, a moderate reduction of n-3 HUFA but increased deposition of 18:3n-3 and only moderate deposition of 18:2n-6 can be observed, meaning that flesh n-3/n-6 ratios of >3 are maintained. Furthermore, even salmon fed 100% LO provide n-3 HUFA levels of 0.12 g EPA and 0.28 g DHA, as well as 3.48 g 18:3n-3 and 1.12 g 18:2n-6 per 100 g of salmon flesh. These values are close to the recommended 0.22 g/d each for EPA and DHA, 2.22 g/d for 18:3n-3, and are well below the maximum recommended intake of 18:2n-6 of 6.67 g/d (39) . However, increasing the dietary n-3/n-6 ratio is also recommended, especially the level of n-3 HUFA of marine origin (39, 40) .
This study has demonstrated mechanisms by which the ratio of DHA/EPA/18:3n-3/18:2n-6 can be manipulated in salmon flesh so that precise "tailored" EFA compositions can be delivered to human consumers. This can be achieved via the initial dietary input, for the majority of the ongrowing phase, and by the use of a FO finishing diet to restore the values of the aforementioned EFA to the desired concentrations. The latter procedure restored both EPA and DHA concentrations in flesh to >80% of the value in fish fed FO throughout the 24 wk, whereas18:2n-6 and 18:3n-3 concentrations were 74% and 1344% higher than in fish fed FO. These results are similar to previous studies with Atlantic salmon and gilthead seabream, which showed that restoration of the flesh EPA and DHA concentrations can be achieved relatively easily with finishing diets but that C 18 PUFA concentrations still remain elevated (14, 48, 49) . A recent study of Atlantic salmon described a dilution model that allowed changes in flesh FA to be accurately predicted following a switch from vegetable oil to FO diets (50). The model described by Jobling (50) supports the results of the present study, which showed that relatively constant concentrations for DHA and EPA were found after feeding the FO finishing diet for 16 or 24 wk.
In conclusion, this study suggests that Atlantic salmon can be cultured, during the marine phase of their life cycle, by using diets in which the FO is replaced by LO without any apparent reduction in the growth rates or health of the fish. In addition, culturing salmon with diets containing up to 50% LO, or up to 100% LO followed by a period of 16-24 wk on an FO finishing diet, can provide a carcass EFA composition that is highly beneficial for human health. Although the goal of minimizing reliance on marine raw materials cannot be achieved overnight, this study suggests that salmon can be cultured on diets with minimal FO input yet still retain a high functional nutritional value that cannot be replicated in terrestrial farmed foodstuffs.
